Olopatadine
Drug Status in USA : Approved
Drug Status in Canada : Approved
Indication : Why is this medication prescribed?
Allergic conjunctivitis.
Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Hypersensitivity. Pregnancy and lactation.Other Precaution to be observed while taking this medication
Remove contact lenses prior to admin. Reinsert soft contact lenses 10 min after admin.
What are possible side effects of this medication ?
Headache, asthenia, cold syndrome, pharyngitis, rhinitis, sinusitis, dysgeusia, ocular burning or stinging, dry eye, foreign body sensation, hyperaemia, keratitis, lid oedema, ocular pruritus, blurred vision.
Drug Category/Class
- Anti-Allergic Agents
- Histamine H1 Antagonists
- Histamine H1 Antagonists, Non-Sedating
- Histamine Antagonists
- Ophthalmologicals
- Sensory Organs
- Nasal Preparations
- Decongestants and Antiallergics
- Antiallergic Agents, Excl. Corticosteroids
- Anti-Inflammatory Agents, Non-Steroidal
- CYP3A4 Inhibitors
- Respiratory System
- Antiallergic agents, excl. corticosteroids
- Other antiallergics
| Prescribed | For the treatment of ocular itching associated with allergic conjunctivitis. |
| Weight : | 337.4122 |
| Structure | Olopatadine |
 |
| Formula | C21H23NO3 |
Olopatadine has 23 Brands listed
Search Generic Drugs alphabetically